Molecular differentiation and antifungal susceptibility of Candida albicans isolated from patients with respiratory infections in Guiyang Medical College Hospital, China

Japanese Journal of Medical Mycology

Volumn 50, Issue 3, 2009, Pages 175-178

  Liu, Ying ^a   Kang, Yingqian ^a,b   Yokoyama, Koji ^a   Gonoi, Tohru ^a   Mikami, Yuzuru ^a  

^a CHIBA UNIVERSITY   (Japan)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Candida albicans; China; Clinical isolates; Drug susceptibility; Genotypes

Indexed keywords

AMPHOTERICIN B; FLUCYTOSINE; MICAFUNGIN; PYRROLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CHINA; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGAL STRAIN; GENOTYPE; HUMAN; JAPANESE; RESPIRATORY TRACT INFECTION;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA ALBICANS; CANDIDIASIS; CHINA; DRUG RESISTANCE, FUNGAL; GENOTYPE; HUMANS; JAPAN; RESPIRATORY TRACT INFECTIONS;

CANDIDA ALBICANS;

EID: 69249132564     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.50.175     Document Type: Article

References (11)

1. Melo NR, Taguchi H, Culhari VP, Kamei K, Mikami Y, Smith SN, Vilela MS: Oral candidiasis of HIV-infected children undergoing sequential HIV therapies. Med Mycol 47: 149-156, 2009.
2. Lee MK, Kim HR, Kang JO, Kim MN, Kim JS, Park YJ, Song W, Shin JM, Lee KM, Lee NY, Lee WG, Lee CK, Lee HL, Cho TY: Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicenter study. Mycoses 50: 148-149, 2007. (Pubitemid 46257145)
3. Tamura M, Watanabe K, Mikami Y, Yazawa K, Nishimura K: Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: Analysis reveals a new genotype of C. albicans with group I intron. J Clin Microbiol 39: 4309-4315, 2001. (Pubitemid 33117115)
4. McCullough MJ, Clemons KV, Stevens DA: Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol 37: 417-421, 1997.
5. She X-D, Wang X-J, Fu M-N, Shen Y-N, Liu W-D: Genotype comparisons of strains of Candida albicans from patients with cutaneous candidiasis and vaginal candidiasis. Chin Med J 121: 1450-1455, 2008.
6. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard - second edition M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA 22 (15): 2002.
7. Uchida K, Nishiyama Y, Yamaguchi H: Studies of the correlation of the method currently used by the Japanese Society for Medical Mycology and its modified method with the NCCLS 27-A2 microdilution method for azole susceptibility testing of Candida species. Jpn J Med Mycol 47: 209-217, 2006. (Pubitemid 44357808)
8. Makimura K, Oguri T, Mikami Y, Kume H, Hanazawa R, Abe M, Ikeda R, Shinoda T: Multicenter evaluation of commercial frozen plates for microdilution broth antifungal susceptibility testing of yeasts and comparison of MIC limits recommended in NCCLS M27-A2. Microbiol Immunol 49: 97-106, 2005. (Pubitemid 40364130)
9. Pfaller MA, Arikan S, Lozano-Chiu M, Chen Y-S, Coffman S, Messer SA, Rennie R, Sand C, Heffner T, Rex JH, Wand J, Yamane N: Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing. J Clin Microbiol 36: 2609-2612, 1998.
10. Koga-Ito CV, Kyon JP, Resende MA: Comparison between E-test and CLSI broth microdilution method for antifungal susceptibility testing of Candida albicans oral isolates. Rev Inst Med Trop Sao Paulo 50: 7-10, 2008.
11. Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA: Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother 53: 217-224, 2004.